Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open Label Extension Study of Etripamil Nasal Spray in PSVT
NCT04952610Phase 3Completed
- Sponsor
- Milestone Pharmaceuticals
- Start
- Dec 2021
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of etripamil in paroxysmal supraventricular tachycardia (PSVT), sponsored by Milestone Pharmaceuticals. Started Dec 2021; status: completed.
02
Drugs
etripamil
03
Conditions
paroxysmal supraventricular tachycardia (PSVT)
Beyond the preview
Go deeper on NCT04952610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04952610.